Revance Publishes its 2022 Environmental, Social, and Governance (ESG) Report

Author's Avatar
Mar 30, 2023

Revance+Therapeutics%2C+Inc. (RVNC), today announced the release of its 2022 ESG Report, detailing the company’s progress towards its ESG priorities of innovation and access, workplace culture and strong corporate governance. The report was guided by the Sustainability Accounting Standards Board (SASB) framework.